Group leader
Today took place the Forum on Next-generation Bioengineering organized by the Institute for Bioengineering of Catalonia (IBEC) and Ulsan National Institute of Science & Technology (UNIST) in South Korea. The event highlighted cutting-edge research in bioengineering and reinforced the collaborative ties between the two institutions.
Researchers at the Soft Robotics Lab at ETH Zurich in collaboration with the Institute for Bioengineering of Catalonia have developed a biohybrid system that mimics the biological interface between bones and muscles, enabling improved force transmission. This technology could be applied not only in robotics but also in the development of medical implants.
Seven more research groups at the Institute for Bioengineering of Catalonia (IBEC) have been certified by My Green Lab, reaching the highest rating, the Green Level, for sustainable laboratory practices. With these additions, IBEC core facilities and 70% of the Institute’s laboratories are now certified.
The joint ICMS-IBEC-MPIP symposium took place today, 24 March. The event was jointly organised by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Complex Molecular Systems (ICMS) and the Max Planck Institute for Polymer Research (MPIP). During the day, researchers from the three centres presented their areas of research, with the aim of strengthening the scientific relations between the institutions.
MWC 2025, the leading international event in technology and connectivity, took place in Barcelona this week. The Institute for Bioengineering of Catalonia was present, showcasing some of its spin-offs and participating in conferences and panels on digital health and technology transfer.
A study led by the Institute for Bioengineering of Catalonia (IBEC) and Pohang University of Science and Technology (POSTECH) in South Korea describes the development of urea-powered nanomotors that improve immunotherapy for bladder cancer. The nanomotors activate the immune system more efficiently and exceed the efficacy of currently used treatments, opening up new possibilities in oncology.
IBEC spin-off Nanobots Therapeutics has been selected in the AECC’s 2024 call for IMPACTO grants. This is an initiative of the Spanish Association Against Cancer (AECC) aimed at technology-based micro-enterprises and SMEs to accelerate the arrival of new treatments in the clinic. The grants were awarded in Barcelona today.
Today, the BIST Forum, an event that brings together the BIST scientific community, focused this year on the joint initiative of the seven CERCA centres to promote precision medicine in healthy ageing. During the event, the new BIST Ignite projects to promote multidisciplinary research were announced, with IBEC involved in four of the five selected projects. In addition, one of the projects in which IBEC is involved won a BIST Ignite Award.
El Dr. Samuel Sánchez, director del grupo de investigación de nanobiodispositivos del Instituto de Bioingeniería de Cataluña (IBEC) y cofundador de Nanobots Therapeutics, ha desarrollado nanorobots capaces de reducir en … Read more
La start-up catalana Nanobots Therapeutics, una spin-off del Instituto de Bioingeniería de Catalunya, ha captado 960.000 euros de capital privado.